Author, year | Age, sex | Time to presentation | Recurrence | Treatment | Initial VA | Outcome |
---|---|---|---|---|---|---|
Adams, 2006 [9] | 73, female | < 24 h post op | 7 months post initial endophthalmitis | Vitrectomy and posterior capsulotomy; intravitreal ceftazidime, vancomycin and dexamethasone; oral ciprofloxacin, topical prednisolone, chloramphenicol and gentamicin | Final BCVA 6/6 | |
Seo, 2008 [12] | 62, male | 3 months post op | Nil | Vitrectomy, lens removal, intravitreal ceftazidime | Final BCVA 20/300 | |
Garrido, 2014 [10] | 67, female | Day 3 post op | Nil | Intravitreal vancomycin and ceftazidime; topical dexamethasone; intravenous ceftazidime | Evisceration | |
Huang, 2015 [14] | ||||||
Kelkar, 2016 [11] | - | Day 1 post op | - | - | Final BCVA 20/200 | |
Mitra, 2018 [13] | 16, male | 1 month post op | Nil | Intravitreal vancomycin, ceftazidime and dexamethasone; oral ciprofloxacin; topical moxifloxacin and prednisolone | Final BCVA 20/60 | |
Agarwal, 2019 [4] | 17, male | Day 2 post op | Nil | 3x vitrectomies; 3x courses of ceftazidime and gentamycin | Non-responsive to treatment, phthisis bulbi, NPL |